High Throughput Screening Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Component (Instruments, Reagents & Assay Kits , Consumables & Accessories, Software and Services), Technology (Bioinformatics, Lab-On-A-Chip, Label-Free Technology, Cell Based Assay and Ultra-High-Throughput Screening), Application (Primary & Secondary Screening, Target Identification & Validation, Toxicology Assessment and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Others), and Geography
Request Now
High-throughput screening (HTS) is an approach to target validation that allows assaying a large number of potential biological modulators against a chosen set of defined targets. The high- throughput screening methods are extensively used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biochemical activity of a large number of molecules.
The high throughput screening market is anticipated to grow with a significant rate in the coming years, owing to owing to large spending on pharmaceutical R&D and technological advancements in HTS. However, the rising prevalence of numerous diseases is anticipated to offer more growth opportunities for the players operating in the high throughput screening market.
The "Global High Throughput Screening Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by component, technology, application, end user, and geography. The global high throughput screening market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading high throughput screening market players and offers key trends and opportunities in the market.
The global high throughput screening market is segmented on the basis of component, technology, application and end user. Based on component, the high throughput screening market is segmented as, instruments, reagents & assay kits, consumables & accessories, software and services. The market by technology segment is segmented into bioinformatics, lab-on-a-chip, label-free technology, cell based assay and ultra-high-throughput screening. On the basis of application, the high throughput screening market is categorized as, primary & secondary screening, target identification & validation, toxicology assessment and others. On the basis of end user, the high throughput screening market is categorized as, pharmaceutical & biotechnology companies, academic & government institutes, contract research organizations (CRO) and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global high throughput screening market based on component, technology, application and end user. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The high throughput screening market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the high throughput screening market in the coming years, due to increasing pharmaceutical R&D and increased government funding for life science research in the region. However, Asia Pacific is expected to witness significant growth in the market during the forecast period, due to huge investments by the pharmaceutical industry in the region.
The report analyzes factors affecting high throughput screening market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the high throughput screening market in these regions.
The report also includes the profiles of key high throughput screening companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the high throughput screening market include, Thermo Fisher Scientific Inc., Danaher, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Agilent Technologies, Inc., Merck KGaA, BioTek Instruments, Inc., Hamilton Company, Corning Incorporated, Tecan Trading AG and among others.